跳至主要内容
临床试验/DRKS00007816
DRKS00007816已完成未知

Vitamin D supplementation in patients with fatty liver and vitamin D deficiency

Saarland University Medical Center Department of Internal Medicine II0 个研究点目标入组 40 人开始时间: 2015年2月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Men and Women >18 years
  • - Patients with hepatic steatosis (>280 dB/m using CAP)
  • - Patients with vitamin D deficiency (serum 25-hydroxyvitamin D <20 ng/ml)

排除标准

  • severe hepatic encephalopathy (CFF <35 Hz)
  • - Interferon treatment
  • - hypercalcaemia (>2.7 mmol/l) or hypercalciuria (>8.0 mmol/d) with or without hyperparathyroidism (>65.0 pg/ml)
  • - history of calcium-containing kidney stones
  • - allergy or hypersensitivity to any of the supplement ingredients: peanuts, soy, gelatin
  • - sarcoidosis
  • - stage IV or V Chronic Kidney Disease
  • - Pregnancy
  • - Liver cirrhosis (Fibroscan, TE >13kPa)
  • - Alcohol consumption

研究者

发起方
Saarland University Medical Center Department of Internal Medicine II

相似试验

Vitamin D supplementation in patients with fatty... | 临床试验